Medicare Enrolled
Dr. Geetha Kamath, MD
Medical Oncology · St Petersburg, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kamath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kamath?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kamath
Dr. Geetha Kamath is a medical oncology specialist in St Petersburg, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kamath performed 117,242 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kamath received a total of $16,151 from 86 pharmaceutical and/or device companies across 750 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kamath is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 21% volume in FL
$16,151 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 37660 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗117,242
Medicare services
Top 21% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
32,640 | $0 | $4 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
31,500 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
18,680 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 12,960 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 11,830 | $1 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,705 | $8 | $9 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,590 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,565 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,030 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
713 | $93 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
710 | $10 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
362 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
270 | $98 | $378 |
| Anti-nausea injection (ondansetron/Zofran) | 248 | $0 | $9 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
165 | $22 | $84 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
147 | $3 | $11 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
125 | $44 | $189 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
114 | $2 | $7 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
109 | $24 | $156 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
98 | $1 | $3 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
94 | $17 | $59 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
80 | $10 | $42 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
63 | $49 | $178 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
54 | $26 | $156 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
48 | $94 | $285 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
47 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 46 | $157 | $585 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $131 | $474 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
44 | $2 | $8 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
39 | $4 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $60 | $239 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $137 | $556 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
18 | $11 | $56 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
17 | $63 | $197 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $116 | $453 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $135 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
55.4% high complexity
40.7% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,151
Total received (2018-2024)
Avg $2,307/year across 7 years
Top 31% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
750
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,721
2023
$3,537
2022
$2,426
2021
$108
2020
$1,525
2019
$2,619
2018
$2,214
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,261
Takeda Pharmaceuticals U.S.A., Inc.
$189
Daiichi Sankyo Inc.
$174
E.R. Squibb & Sons, L.L.C.
$161
AstraZeneca Pharmaceuticals LP
$148
Merck Sharp & Dohme LLC
$145
Janssen Biotech, Inc.
$143
Alexion Pharmaceuticals, Inc.
$85
Exelixis Inc.
$77
Gilead Sciences, Inc.
$75
ARRAY BIOPHARMA INC
$65
JAZZ PHARMACEUTICALS INC.
$62
TAIHO ONCOLOGY, INC.
$58
GlaxoSmithKline, LLC.
$58
Blueprint Medicines Corporation
$57
ABBVIE INC.
$56
Stemline Therapeutics Inc.
$56
PFIZER INC.
$55
Incyte Corporation
$54
Celgene Corporation
$53
Eisai Inc.
$49
Pharmacosmos Therapeutics Inc.
$40
Mirati Therapeutics, Inc.
$39
SOBI, INC
$38
PUMA BIOTECHNOLOGY, INC.
$38
TerSera Therapeutics LLC
$37
Regeneron Healthcare Solutions, Inc.
$35
Tempus AI, Inc
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
Kite Pharma, Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Lilly USA, LLC
$30
Adaptive Biotechnologies Corporation
$29
Legend Biotech USA Inc.
$29
BeiGene USA, Inc.
$27
PharmaEssentia USA Corporation
$27
Fennec Pharmaceuticals, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
Genentech USA, Inc.
$23
GENZYME CORPORATION
$20
Sumitomo Pharma America, Inc.
$20
Fresenius Kabi USA, LLC
$19
Insmed, Inc.
$16
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,872
E.R. Squibb & Sons, L.L.C.
$969
Janssen Biotech, Inc.
$855
Daiichi Sankyo Inc.
$560
Merck Sharp & Dohme Corporation
$509
Lilly USA, LLC
$463
Amgen Inc.
$434
Astellas Pharma US Inc
$433
Celgene Corporation
$429
GENZYME CORPORATION
$385
AstraZeneca Pharmaceuticals LP
$380
PFIZER INC.
$379
Merck Sharp & Dohme LLC
$378
Genentech USA, Inc.
$377
Incyte Corporation
$373
NOVARTIS PHARMACEUTICALS CORPORATION
$321
Takeda Pharmaceuticals U.S.A., Inc.
$260
Gilead Sciences, Inc.
$256
Seattle Genetics, Inc.
$247
Seagen Inc.
$233
Regeneron Healthcare Solutions, Inc.
$210
Exelixis Inc.
$205
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
JAZZ PHARMACEUTICALS INC.
$187
Eisai Inc.
$163
GlaxoSmithKline, LLC.
$154
Puma Biotechnology, Inc.
$154
ARRAY BIOPHARMA INC
$138
SOBI, INC
$125
EISAI INC.
$108
Kite Pharma, Inc.
$107
Blueprint Medicines Corporation
$105
Stemline Therapeutics Inc.
$103
Alexion Pharmaceuticals, Inc.
$102
PUMA BIOTECHNOLOGY, INC.
$97
TerSera Therapeutics LLC
$90
Pharmacosmos Therapeutics Inc.
$88
ABBVIE INC.
$85
Rigel Pharmaceuticals, Inc.
$79
G1 Therapeutics, Inc.
$75
TAIHO ONCOLOGY, INC.
$73
Sumitomo Pharma America, Inc.
$61
PharmaEssentia USA Corporation
$59
Mirati Therapeutics, Inc.
$56
Spectrum Pharmaceuticals Inc.
$53
AbbVie, Inc.
$51
EMD Serono, Inc.
$50
Janssen Pharmaceuticals, Inc
$49
Bayer HealthCare Pharmaceuticals Inc.
$48
Sysmex Inostics Inc
$46
BeiGene USA, Inc.
$44
EUSA Pharma (US) LLC
$41
Taiho Oncology, Inc.
$38
Karyopharm Therapeutics Inc.
$38
Sun Pharmaceutical Industries Inc.
$37
Sobi, Inc
$35
Tempus AI, Inc
$34
Helsinn Therapeutics (U.S.), Inc.
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
MEDIVATION FIELD SOLUTIONS LLC
$32
Agios Pharmaceuticals, Inc.
$31
Pharmacyclics LLC, an AbbVie Company
$31
Ipsen Biopharmaceuticals, Inc
$30
Adaptive Biotechnologies Corporation
$29
Legend Biotech USA Inc.
$29
Aurobindo Pharma USA, Inc.
$26
Clovis Oncology, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Fennec Pharmaceuticals, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
AVEO Pharmaceuticals, Inc.
$23
Partner Therapeutics, Inc.
$22
TESARO, Inc.
$21
GE HealthCare
$19
SANOFI-AVENTIS U.S. LLC
$19
Array BioPharma Inc.
$19
CTI BioPharma Corp.
$19
Fresenius Kabi USA, LLC
$19
Myriad Genetic Laboratories, Inc.
$19
Mylan Pharmaceuticals Inc.
$19
Lexicon Pharmaceuticals, Inc.
$18
Insmed, Inc.
$16
Deciphera Pharmaceuticals Inc.
$15
Kyowa Kirin, Inc.
$14
Myovant Sciences Inc.
$13
Acrotech Biopharma LLC
$13
Top 3 companies account for 35.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Arikayce · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CARVYKTI · CEREZYME · COSELA · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMEND · ENHERTU · ENJAYMO · ERLEADA · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · Fulphila · GAUCHER-DISEASE · GAZYVA · GILOTRIF · HEMADY · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OJJAARA · ONPATTRO · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POLIVY · PROMACTA · Padcev · Pedmark · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · Rituxan Hycela · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SUTENT · Somatuline Depot · Stimufend · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
64
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA NORTHSIDE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kamath is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kamath experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kamath performed 32,640 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kamath receive payments from pharmaceutical companies?
Yes. Dr. Kamath received a total of $16,151 from 86 companies across 750 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kamath's costs compare to other medical oncologists in St Petersburg?
Dr. Kamath's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kamath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in St Petersburg
Browse medical oncologists in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology